These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33746084)

  • 41. JNKs protect from cholestatic liver disease progression by modulating Apelin signalling.
    Mohamed MR; Haybaeck J; Wu H; Su H; Bartneck M; Lin C; Boekschoten MV; Boor P; Goeppert B; Rupp C; Strnad P; Davis RJ; Cubero FJ; Trautwein C
    JHEP Rep; 2023 Nov; 5(11):100854. PubMed ID: 37791376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.
    Thompson MD; Moghe A; Cornuet P; Marino R; Tian J; Wang P; Ma X; Abrams M; Locker J; Monga SP; Nejak-Bowen K
    Hepatology; 2018 Mar; 67(3):955-971. PubMed ID: 28714273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective Inhibition of Hepatic Stellate Cell and Fibroblast-derived LOXL1 Attenuates BDL and Mdr2
    Yan X; Zhang N; Wei L; Zhang W; Huang T; Li W; Chen W; Yang A; You H
    Am J Physiol Gastrointest Liver Physiol; 2023 Oct; ():. PubMed ID: 37873581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.
    Yu D; Cai SY; Mennone A; Vig P; Boyer JL
    Liver Int; 2018 Jun; 38(6):1128-1138. PubMed ID: 29356312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of necroptosis in human and experimental cholestasis.
    Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
    Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network.
    Zhang Y; Xu N; Xu J; Kong B; Copple B; Guo GL; Wang L
    Hepatology; 2014 Sep; 60(3):919-30. PubMed ID: 24619556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Organic Anion Transporting Polypeptide (OATP) 1B3 is a Significant Transporter for Hepatic Uptake of Conjugated Bile Acids in Humans.
    Pan Q; Zhu G; Xu Z; Zhu J; Ouyang J; Tong Y; Zhao N; Zhang X; Cheng Y; Zhang L; Tan Y; Li J; Zhang C; Chen W; Cai SY; Boyer JL; Chai J
    Cell Mol Gastroenterol Hepatol; 2023; 16(2):223-242. PubMed ID: 37146714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. H19 potentiates let-7 family expression through reducing PTBP1 binding to their precursors in cholestasis.
    Zhang L; Yang Z; Huang W; Wu J
    Cell Death Dis; 2019 Feb; 10(3):168. PubMed ID: 30778047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.
    Nishio T; Hu R; Koyama Y; Liang S; Rosenthal SB; Yamamoto G; Karin D; Baglieri J; Ma HY; Xu J; Liu X; Dhar D; Iwaisako K; Taura K; Brenner DA; Kisseleva T
    J Hepatol; 2019 Sep; 71(3):573-585. PubMed ID: 31071368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of bile duct ligation on bile acid composition in mouse serum and liver.
    Zhang Y; Hong JY; Rockwell CE; Copple BL; Jaeschke H; Klaassen CD
    Liver Int; 2012 Jan; 32(1):58-69. PubMed ID: 22098667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
    Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
    J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1.
    Zhuang Y; Ortega-Ribera M; Thevkar Nagesh P; Joshi R; Huang H; Wang Y; Zivny A; Mehta J; Parikh SM; Szabo G
    Hepatology; 2024 Apr; 79(4):752-767. PubMed ID: 37725754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases.
    Zhang J; Lyu Z; Li B; You Z; Cui N; Li Y; Li Y; Huang B; Chen R; Chen Y; Peng Y; Fang J; Wang Q; Miao Q; Tang R; Gershwin ME; Lian M; Xiao X; Ma X
    Hepatology; 2023 Jul; 78(1):10-25. PubMed ID: 36799463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protective Effects of Peroxiredoxin 4 (PRDX4) on Cholestatic Liver Injury.
    Zhang J; Guo X; Hamada T; Yokoyama S; Nakamura Y; Zheng J; Kurose N; Ishigaki Y; Uramoto H; Tanimoto A; Yamada S
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatic LGR4 aggravates cholestasis-induced liver injury in mice.
    Gao Y; Zhai W; Sun L; Du X; Wang X; Mulholland MW; Yin Y; Zhang W
    Am J Physiol Gastrointest Liver Physiol; 2024 Apr; 326(4):G460-G472. PubMed ID: 38440827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism.
    Jia WJ; Tang QL; Jiang S; Sun SQ; Xue B; Qiu YD; Li CJ; Mao L
    FEBS J; 2020 Aug; 287(15):3328-3345. PubMed ID: 31905247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism.
    Han Q; Yan X; Wang L; Zhang N; Zhang W; Li H; Chen W; You H; Yang A
    Biochem Biophys Res Commun; 2023 Nov; 682():259-265. PubMed ID: 37826949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
    Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns.
    Juanola O; Hassan M; Kumar P; Yilmaz B; Keller I; Simillion C; Engelmann C; Tacke F; Dufour JF; De Gottardi A; Moghadamrad S
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 33847205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic miR-378 modulates serum cholesterol levels by regulating hepatic bile acid synthesis.
    Sun C; Liu W; Lu Z; Li Y; Liu S; Tang Z; Yan Y; Li Z; Feng H; Zhang D; Liu Y; Fang ZZ; Jiang C; Ding Q; Jiang J; Ying H
    Theranostics; 2021; 11(9):4363-4380. PubMed ID: 33754066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.